Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets
- PMID: 25880175
- PMCID: PMC5337058
- DOI: 10.5152/akd.2014.5263
Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets
Abstract
Objective: The heterogeneity in the degree of collateralization among patients with coronary artery disease (CAD) remains incompletely understood. We evaluated the predictors of poorly developed coronary collateral circulation (CCC) in patients with stable coronary artery disease.
Methods: Current study is a retrospective study, consisting of 118 patients with poor CCC and 130 patients with good CCC. We investigated predictors of poor coronary collaterals in a cohort of 248 patients who had high-grade coronary stenosis or occlusion on their angiograms. To classify CCC, we used the Rentrop classification.
Results: Patients with poorly developed CCC had significantly higher neutrophil-to-lymphocyte ratio (N/L) compared with those with well-developed CCC, (4.2±2.8 vs. 3±3.1, p=0.001), whereas mean platelet volume, red cell distribution width and uric acid were not significantly different. Logistic regression analysis showed that N/L ratio (odds ratio 1.199, 95% confidence interval 1.045-1.375) and serum triglyceride levels [odds ratio (OR)=1.006, 95% confidence interval (CI)=1.001-1.010] were independent predictors of poorly developed CCC.
Conclusion: An elevated level of N/L ratio is independently associated with a significant impairment in coronary collateralization. Our findings suggest that N/L ratio is an inexpensive, universally available hematological marker for sufficiency of CCC in patients with stable coronary artery disease.
Conflict of interest statement
Figures
Comment in
-
Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets.Anatol J Cardiol. 2015 Nov;15(11):960-1. doi: 10.5152/AnatolJCardiol.2015.6522. Anatol J Cardiol. 2015. PMID: 26574770 Free PMC article. No abstract available.
-
Author's Reply.Anatol J Cardiol. 2015 Nov;15(11):961. Anatol J Cardiol. 2015. PMID: 26904757 Free PMC article. No abstract available.
References
-
- Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986;74:469–76. [CrossRef] - PubMed
-
- Williams DO, Amsterdam EA, Miller RR, Mason DT. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol. 1976;37:345–51. [CrossRef] - PubMed
-
- Billinger M, Kloos P, Eberli FR, Windecker S, Meier B, Seiler C. Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease. J Am Coll Cardiol. 2002;40:1545–50. [CrossRef] - PubMed
-
- Abaci A, Oguzhan A, Kahraman S, Eryol NK, Ünal S, Arınç H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999;99:2239–42. [CrossRef] - PubMed
-
- Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Qengel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis. 2008;197:753–6. [CrossRef] - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous